| Bioactivity | Zaurategrast (CT7758) is a potent and oral-effective α4-integrin inhibitor[1]. | ||||||||||||
| Target | α4-integrin | ||||||||||||
| Invitro | Zaurategrast (CT7758) is a carboxylate containing α4β1/α4/β7 integrin antagonist[1]. | ||||||||||||
| Name | Zaurategrast | ||||||||||||
| CAS | 455264-31-0 | ||||||||||||
| Formula | C26H25BrN4O3 | ||||||||||||
| Molar Mass | 521.41 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Hugues Chanteux , et al. Cross-Species Differences in the Preclinical Pharmacokinetics of CT7758, an α4β1/α4β7 Integrin Antagonist. Drug Metab Dispos. 2015 Sep;43(9):1381-91. |